The DOI matches its Crossref record; 81 of the 81 references it cites were found in a registry or an index.
Cancer-associated stroke: Pathophysiology, detection and management (Review)
Open accessAbstract
Numerous types of cancer have been shown to be associated with either ischemic or hemorrhagic stroke. In this review, the epidemiology and pathophysiology of stroke in cancer patients is discussed, while providing vital information on the diagnosis and management of patients with cancer and stroke. Cancer may mediate stroke pathophysiology either directly or via coagulation disorders that establish a state of hypercoagulation, as well as via infections. Cancer treatment options, such as chemotherapy, radiotherapy and surgery have all been shown to aggravate the risk of stroke as well. The clinical manifestation varies greatly depending upon the underlying cause; however, in general, cancer‑associated strokes tend to appear as multifocal in neuroimaging. Furthermore, several serum markers have been identified, such as high D‑Dimer levels and fibrin degradation products. Managing cancer patients with stroke is a delicate matter. The cancer should not be considered a contraindication in applying thrombolysis and recombinant tissue plasminogen activator (rTPA) administration, since the risk of hemorrhage in cancer patients has not been reported to be higher than that in the general population. Anticoagulation, on the contrary, should be carefully examined. Clinicians should weigh the benefits and risks of anticoagulation treatment for each patient individually; the new oral anticoagulants appear promising; however, low‑molecular‑weight heparin remains the first choice. On the whole, stroke is a serious and not a rare complication of malignancy. Clinicians should be adequately trained to handle these patients efficiently.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Edoxaban for the Treatment of Cancer-Associated Venous Thromboembolism
Raskob, G. E., van Es, N., Verhamme, P., Carrier, M., Di Nisio, M., Garcia, D., Grosso, M. A., Kakkar, A. K., Kovacs, M. J., Mercuri, M. F., et al. (2018) · New England Journal of Medicine · doi:10.1056/nejmoa1711948 · Cited by 1,633
Cerebrovascular Complications in Patients with Cancer
GRAUS, F., ROGERS, L. R., & POSNER, J. B. (1985) · Medicine · doi:10.1097/00005792-198501000-00002 · Cited by 618
Nonbacterial thrombotic endocarditis: A review
López, J. A. G., Ross, R. S., Fishbein, M. C., & Siegel, R. J. (1987) · American Heart Journal · doi:10.1016/0002-8703(87)90719-8 · Cited by 401
Increased Risk of Ischemic Stroke After Radiotherapy on the Neck in Patients Younger Than 60 Years
Dorresteijn, L. D. A., Kappelle, A. C., Boogerd, W. J., Klokman, W. J., Balm, A. J. M., Keus, R. B., van Leeuwen, F. E., & Bartelink, H. (2002) · Journal of Clinical Oncology · doi:10.1200/jco.20.1.282 · Cited by 385
Stroke in patients with cancer: Incidence and etiology
Cestari, D. M., Weine, D. M., Panageas, K. S., Segal, A. Z., & DeAngelis, L. M. (2004) · Neurology · doi:10.1212/01.wnl.0000129912.56486.2b · Cited by 379
Rominger, A., Saam, T., Wolpers, S., Cyran, C. C., Schmidt, M., Foerster, S., Nikolaou, K., Reiser, M. F., Bartenstein, P., & Hacker, M. (2009) · Journal of Nuclear Medicine · doi:10.2967/jnumed.109.065151 · Cited by 362
Nonbacterial Thrombotic Endocarditis in Cancer Patients: Pathogenesis, Diagnosis, and Treatment
el-Shami, K., Griffiths, E., & Streiff, M. (2007) · The Oncologist · doi:10.1634/theoncologist.12-5-518 · Cited by 318
Association between incident cancer and subsequent stroke
Navi, B. B., Reiner, A. S., Kamel, H., Iadecola, C., Elkind, M. S. V., Panageas, K. S., & DeAngelis, L. M. (2015) · Annals of Neurology · doi:10.1002/ana.24325 · Cited by 252
Bowers, D. C., McNeil, D. E., Liu, Y., Yasui, Y., Stovall, M., Gurney, J. G., Hudson, M. M., Donaldson, S. S., Packer, R. J., Mitby, P. A., et al. (2005) · Journal of Clinical Oncology · doi:10.1200/jco.2005.15.107 · Cited by 233
Increased Risk of Stroke and Transient Ischemic Attack in 5-Year Survivors of Hodgkin Lymphoma
De Bruin, M. L., Dorresteijn, L. D. A., van't Veer, M. B., Krol, A. D. G., van der Pal, H. J., Kappelle, A. C., Boogerd, W., Aleman, B. M. P., & van Leeuwen, F. E. (2009) · JNCI: Journal of the National Cancer Institute · doi:10.1093/jnci/djp147 · Cited by 232
Cited by
Kleindorfer, D. O., Towfighi, A., Chaturvedi, S., Cockroft, K. M., Gutierrez, J., Lombardi-Hill, D., Kamel, H., Kernan, W. N., Kittner, S. J., Leira, E. C., et al. (2021) · Stroke · doi:10.1161/str.0000000000000375 · Cited by 3,237
Bushnell, C., Kernan, W. N., Sharrief, A. Z., Chaturvedi, S., Cole, J. W., Cornwell, W. K., Cosby-Gaither, C., Doyle, S., Goldstein, L. B., Lennon, O., et al. (2024) · Stroke · doi:10.1161/str.0000000000000475 · Cited by 360
Metadata
- Authors
- Dardiotis, E., Aloizou, A.-M., Markoula, S., Siokas, V., Tsarouhas, K., Tzanakakis, G., Libra, M., Kyritsis, A., Brotis, A., Aschner, M., Gozes, I., Bogdanos, D., Spandidos, D., Mitsias, P., & Tsatsakis, A.
- Venue
- International Journal of Oncology
- Publisher
- Spandidos Publications
- Published
- 2019-01-02
- Volume
- 54
- Issue
- 3
- Pages
- 779-796
- ISSN
- 1019-6439 (ISSN-L)
- 1791-2423
- OpenAlex
- W2908198628
- Cited by
- 275
- References
- 81
- FWCI
- 20.53
- Type
- journal article
- Language
- en
- Open access
- hybrid
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Cancer-associated stroke: Pathophysiology, detection and management (Review). https://app.cochat.ai/papers/10.3892/ijo.2019.4669
- The paper
- Dardiotis, E., Aloizou, A.-M., Markoula, S., Siokas, V., Tsarouhas, K., Tzanakakis, G., Libra, M., Kyritsis, A., Brotis, A., Aschner, M., Gozes, I., Bogdanos, D., Spandidos, D., Mitsias, P., & Tsatsakis, A. (2019). Cancer-associated stroke: Pathophysiology, detection and management (Review). International Journal of Oncology. https://doi.org/10.3892/ijo.2019.4669
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.